Synergy Innovation Co. Ltd (048870) - Total Assets

Latest as of September 2025: ₩335.45 Billion KRW ≈ $227.33 Million USD

Based on the latest financial reports, Synergy Innovation Co. Ltd (048870) holds total assets worth ₩335.45 Billion KRW (≈ $227.33 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Synergy Innovation Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Synergy Innovation Co. Ltd - Total Assets Trend (2006–2024)

This chart illustrates how Synergy Innovation Co. Ltd's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Synergy Innovation Co. Ltd to see how much of total assets are deployed in long-term investments.

Synergy Innovation Co. Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Synergy Innovation Co. Ltd's total assets of ₩335.45 Billion consist of 47.4% current assets and 52.6% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 22.8%
Accounts Receivable ₩16.35 Billion 5.2%
Inventory ₩20.45 Billion 6.5%
Property, Plant & Equipment ₩24.96 Billion 8.0%
Intangible Assets ₩3.28 Billion 1.1%
Goodwill ₩18.35 Billion 5.8%

Asset Composition Trend (2006–2024)

This chart illustrates how Synergy Innovation Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Synergy Innovation Co. Ltd stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Synergy Innovation Co. Ltd's current assets represent 47.4% of total assets in 2024, an increase from 0.0% in 2006.
  • Cash Position: Cash and equivalents constituted 22.8% of total assets in 2024, down from 24.0% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 19.0% in 2006.
  • Asset Diversification: The largest asset category is property, plant & equipment at 8.0% of total assets.

Synergy Innovation Co. Ltd Competitors by Total Assets

Key competitors of Synergy Innovation Co. Ltd based on total assets are shown below.

Company Country Total Assets
Ascendis Pharma AS
NASDAQ:ASND
USA $2.01 Billion
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
USA $8.59 Billion
Spyre Therapeutics Inc.
NASDAQ:SYRE
USA $763.95 Million
3SBio Inc
F:83B
Germany €36.25 Billion
Soleno Therapeutics Inc
NASDAQ:SLNO
USA $608.39 Million
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
China CN¥4.48 Billion
Novavax Inc
NASDAQ:NVAX
USA $1.04 Billion
BB Biotech AG
SW:BION
Switzerland CHF2.64 Billion

Synergy Innovation Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.52 2.01 1.24
Quick Ratio 2.11 1.78 1.01
Cash Ratio 0.00 0.00 0.00
Working Capital ₩82.50 Billion ₩69.17 Billion ₩12.41 Billion

Synergy Innovation Co. Ltd - Advanced Valuation Insights

This section examines the relationship between Synergy Innovation Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.00
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 9.8%
Total Assets ₩314.06 Billion
Market Capitalization $107.71 Million USD

Valuation Analysis

Below Book Valuation: The market values Synergy Innovation Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Synergy Innovation Co. Ltd's assets grew by 9.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Synergy Innovation Co. Ltd (2006–2024)

The table below shows the annual total assets of Synergy Innovation Co. Ltd from 2006 to 2024.

Year Total Assets Change
2024-12-31 ₩314.06 Billion
≈ $212.83 Million
+9.85%
2023-12-31 ₩285.90 Billion
≈ $193.75 Million
+25.74%
2022-12-31 ₩227.38 Billion
≈ $154.09 Million
+12.17%
2021-12-31 ₩202.70 Billion
≈ $137.37 Million
+28.04%
2020-12-31 ₩158.31 Billion
≈ $107.29 Million
+7.48%
2019-12-31 ₩147.29 Billion
≈ $99.82 Million
+20.73%
2018-12-31 ₩122.01 Billion
≈ $82.68 Million
+15.03%
2017-12-31 ₩106.06 Billion
≈ $71.87 Million
+77.73%
2016-12-31 ₩59.67 Billion
≈ $40.44 Million
+270.69%
2015-12-31 ₩16.10 Billion
≈ $10.91 Million
-80.39%
2014-12-31 ₩82.08 Billion
≈ $55.62 Million
-15.00%
2013-12-31 ₩96.56 Billion
≈ $65.44 Million
-25.84%
2012-12-31 ₩130.20 Billion
≈ $88.24 Million
+3.31%
2011-12-31 ₩126.03 Billion
≈ $85.41 Million
-11.87%
2009-12-31 ₩143.00 Billion
≈ $96.91 Million
-20.32%
2008-12-31 ₩179.47 Billion
≈ $121.63 Million
+14.60%
2007-12-31 ₩156.60 Billion
≈ $106.13 Million
+14.49%
2006-12-31 ₩136.78 Billion
≈ $92.69 Million
--

About Synergy Innovation Co. Ltd

KQ:048870 Korea Biotechnology
Market Cap
$107.71 Million
₩158.94 Billion KRW
Market Cap Rank
#18998 Global
#908 in Korea
Share Price
₩1804.00
Change (1 day)
-2.70%
52-Week Range
₩1682.00 - ₩3065.00
All Time High
₩19100.00
About

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more